Parents' Perspectives on the Utility of Genomic Sequencing in the Neonatal Intensive Care Unit
- PMID: 37511639
- PMCID: PMC10382030
- DOI: 10.3390/jpm13071026
Parents' Perspectives on the Utility of Genomic Sequencing in the Neonatal Intensive Care Unit
Abstract
Background: It is critical to understand the wide-ranging clinical and non-clinical effects of genome sequencing (GS) for parents in the NICU context. We assessed parents' experiences with GS as a first-line diagnostic tool for infants with suspected genetic conditions in the NICU.
Methods: Parents of newborns (N = 62) suspected of having a genetic condition were recruited across five hospitals in the southeast United States as part of the SouthSeq study. Semi-structured interviews (N = 78) were conducted after parents received their child's sequencing result (positive, negative, or variants of unknown significance). Thematic analysis was performed on all interviews.
Results: Key themes included that (1) GS in infancy is important for reproductive decision making, preparing for the child's future care, ending the diagnostic odyssey, and sharing results with care providers; (2) the timing of disclosure was acceptable for most parents, although many reported the NICU environment was overwhelming; and (3) parents deny that receiving GS results during infancy exacerbated parent-infant bonding, and reported variable impact on their feelings of guilt.
Conclusion: Parents reported that GS during the neonatal period was useful because it provided a "backbone" for their child's care. Parents did not consistently endorse negative impacts like interference with parent-infant bonding.
Keywords: genome sequencing; parental guilt; parent–infant bonding; timing of disclosure of results; utility.
Conflict of interest statement
The authors declare that they have no competing interest.
References
-
- Kingsmore S.F., Henderson A., Owen M.J., Clark M.M., Hansen C., Dimmock D., Chambers C.D., Jeliffe-Pawlowski L.L., Hobbs C. Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing. NPJ Genom. Med. 2020;5:49. doi: 10.1038/s41525-020-00155-8. - DOI - PMC - PubMed
-
- Kingsmore S.F., Cakici J.A., Clark M.M., Gaughran M., Feddock M., Batalov S., Bainbridge M.N., Carroll J., Caylor S.A., Clarke C., et al. A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill Infants. Am. J. Hum. Genet. 2019;105:719–733. doi: 10.1016/j.ajhg.2019.08.009. - DOI - PMC - PubMed